Treatment and Prophylaxis of Post-pericardiotomy Syndrome in Cardiac Surgery Patients: a Systematic Review.
Colchicine
Dexamethasone
Indomethacin
Post-pericardiotomy syndrome
Journal
Cardiovascular drugs and therapy
ISSN: 1573-7241
Titre abrégé: Cardiovasc Drugs Ther
Pays: United States
ID NLM: 8712220
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
accepted:
06
09
2021
medline:
3
8
2023
pubmed:
22
9
2021
entrez:
21
9
2021
Statut:
ppublish
Résumé
Post-pericardiotomy syndrome (PPS) is a common complication of cardiac surgery. This systematic review aimed to investigate the efficacy of colchicine, indomethacin, and dexamethasone in the treatment and prophylaxis of PPS. Literature research was carried out using PubMed. Studies investigating ≥ 10 patients with clinically PPS treated with colchicine, dexamethasone, and indomethacin and compared with placebo were included. Animal or in vitro experiments, studies on < 10 patients, case reports, congress reports, and review articles were excluded. Cochrane risk-of-bias tool for randomized trials (RoB2) was used for the quality assessment of studies. Seven studies were included. Among studies with postoperative colchicine treatment, two of them demonstrated a significant reduction of PPS. In the single pre-surgery colchicine administration study, a decrease of PPS cases was registered. Indomethacin pre-surgery administration was linked to a reduction of PPS. No significant result emerged with preoperative dexamethasone intake. Better outcomes have been registered when colchicine and indomethacin were administered as primary prophylactic agents in preventing PPS and PE. Further RCT studies are needed to confirm these results.
Identifiants
pubmed: 34546452
doi: 10.1007/s10557-021-07261-4
pii: 10.1007/s10557-021-07261-4
pmc: PMC10397136
doi:
Substances chimiques
Colchicine
SML2Y3J35T
Indomethacin
XXE1CET956
Dexamethasone
7S5I7G3JQL
Types de publication
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
771-779Informations de copyright
© 2021. The Author(s).
Références
Mack DR, Cahoon WD, Lowe DK. Colchicine for the primary prevention of the postpericardiotomy syndrome. Ann Pharmacother. 2011;45:803–6. http://journals.sagepub.com/doi/10.1345/aph.1Q112 .
Wan S, LeClerc J-L, Vincent J-L. Inflammatory Response to Cardiopulmonary Bypass. Chest. 1997;112:676–92. https://linkinghub.elsevier.com/retrieve/pii/S0012369216317354.
Dieleman JM, van Paassen J, van Dijk D, Arbous MS, Kalkman CJ, Vandenbroucke JP, et al. Prophylactic corticosteroids for cardiopulmonary bypass in adults. Cochrane Database Syst Rev. 2011. https://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005566.pub3 .
Imazio M, Trinchero R, Brucato A, Rovere ME, Gandino A, Cemin R, et al. Colchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J. 2010;31:2749–54. https://academic.oup.com/eurheartj/articlelookup/doi/10.1093/eurheartj/ehq319 .
Jadad AR, Carroll D, Moore A, McQuay H. Developing a database of published reports of randomised clinical trials in pain research 1. Pain. 1996;66:239–46. http://journals.lww.com/00006396-199608000-00017.
Dieleman JM, de Wit GA, Nierich AP, Rosseel PM, van der Maaten JM, Hofland J, et al. Long-term outcomes and cost effectiveness of high-dose dexamethasone for cardiac surgery: a randomised trial. Anaesthesia. 2017;72:704–13. https://onlinelibrary.wiley.com/doi/10.1111/anae.13853 .
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. https://dx.plos.org/10.1371/journal.pmed.1000097 .
doi: 10.1371/journal.pmed.1000097
pubmed: 19621072
pmcid: 2707599
Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed). 2011;343:d5928.
doi: 10.1136/bmj.d5928
pubmed: 22008217
pmcid: 3196245
Inan MB, Yazıcıoglu L, Eryılmaz S, Sırlak M, Cetıntas D, Kaya B, et al. Effects of prophylactic indomethacin treatment on postoperative pericardial effusion after aortic surgery. J Thorac Cardiovasc Surg. 2011;141:578–82. https://linkinghub.elsevier.com/retrieve/pii/S0022522310003168.
Izadi Amoli A, Bozorgi A, HajHossein Talasaz A, Salehi Omran A, Mortazavi SH, Jalali A, et al. Efficacy of colchicine versus placebo for the treatment of pericardial effusion after open-heart surgery: a randomized, placebo-controlled trial. Am Heart J. 2015;170:1195–201. https://linkinghub.elsevier.com/retrieve/pii/S0002870315006079.
Imazio M, Brucato A, Ferrazzi P, Pullara A, Adler Y, Barosi A, et al. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation. JAMA. 2014;312:1016. http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2014.11026 .
Meurin P, Lelay-Kubas S, Pierre B, Pereira H, Pavy B, Iliou MC, et al. Colchicine for post-operative pericardial effusion. J Am Coll Cardiol. 2015;66:1198–9. https://linkinghub.elsevier.com/retrieve/pii/S0735109715043041.
Finkelstein Y, Shemesh J, Mahlab K, Abramov D, Bar-El Y, Sagie A, et al. Colchicine for the prevention of postpericardiotomy syndrome. Herz. 2002;27:791–4. http://link.springer.com/10.1007/s00059-002-2376-5 .
Bunge JJH, van Osch D, Dieleman JM, Jacob KA, Kluin J, van Dijk D, et al. Dexamethasone for the prevention of postpericardiotomy syndrome: a DExamethasone for Cardiac Surgery substudy. Am Heart J. 2014;168:126–131.e1. https://linkinghub.elsevier.com/retrieve/pii/S000287031400163X.
Imazio M, Brucato A, Cemin R, Ferrua S, Maggiolini S, Beqaraj F, et al. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369:1522–8. http://www.nejm.org/doi/10.1056/NEJMoa1208536 .
van Osch D, Nathoe HM, Jacob KA, Doevendans PA, van Dijk D, Suyker WJ, et al. Determinants of the postpericardiotomy syndrome: a systematic review. Eur J Clin Invest. 2017;47:456–67. https://onlinelibrary.wiley.com/doi/10.1111/eci.12764 .
Erlich JF, Paz Z. Postpericardial injury syndrome: an autoimmune phenomenon. Clin Rev Allergy Immunol. 2010;38:156–8. http://link.springer.com/10.1007/s12016-009-8147-9 .
Kim S, Sahn SA. Postcardiac Injury Syndrome. Chest. 1996;109:570–2. https://linkinghub.elsevier.com/retrieve/pii/S001236921545696X.
Jaworska-Wilczyńska M, Magalska A, Piwocka K, Szymański P, Kuśmierczyk M, Wąsik M, et al. Low interleukin - 8 level predicts the occurrence of the postpericardiotomy syndrome. Pizzi C, editor. PLoS ONE. 2014;9:e108822. https://dx.plos.org/10.1371/journal.pone.0108822 .
Agarwal SK, Vallurupalli S, Uretsky BF, Hakeem A. Effectiveness of colchicine for the prevention of recurrent pericarditis and post-pericardiotomy syndrome: an updated meta-analysis of randomized clinical data. Eur Heart J Cardiovasc Pharmacother. 2015;1:117–25. https://academic.oup.com/ehjcvp/article-lookup/doi/10.1093/ehjcvp/pvv001 .
Lutschinger LL, Rigopoulos AG, Schlattmann P, Matiakis M, Sedding D, Schulze PC, et al. Meta-analysis for the value of colchicine for the therapy of pericarditis and of postpericardiotomy syndrome. BMC Cardiovasc Disord. 2019;19:207. https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-019-1190-4 .